Glycominds, LLC Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Glycominds, LLC operates in the biotechnology research sector as a commercial-stage diagnostics company focused on identifying autoimmune and chronic inflammatory disease biomarkers, with a particular emphasis on inflammatory bowel disease. Based in Simi Valley, California, the company develops diagnostic tools intended to support clinicians in diagnosing and managing inflammatory conditions, positioning itself within the biomedical diagnostics landscape. Its target market includes healthcare providers and researchers seeking biomarker-based solutions to improve understanding and treatment of autoimmune and inflammatory diseases. The organization appears to be a small, specialized firm operating in the United States, concentrating on translating biomarker discoveries into practical diagnostic applications for inflammatory bowel disease and related conditions. A recent development indicates continued activity as a commercial-stage entity, underscoring its progression in bringing diagnostics to market from its base in California.